Using diffusion-weighted imaging and blood inflammatory markers to preoperatively differentiate between leiomyosarcoma and atypical leiomyomas
British Journal of Radiology · 2025
DOI: 10.1093/bjr/tqaf172 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Radiology, 2025. Verfasst von Saranya Das und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, London W12 0NN, United Kingdom. Hauptthemen laut MEDLINE: Leiomyosarcoma, Leiomyoma, Diffusion Magnetic Resonance Imaging, Uterine Neoplasms. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
Objectives
This study aims to compare apparent diffusion coefficient (ADC) findings between leiomyosarcoma (LMS) and atypical/degenerate leiomyoma (LM) and evaluate the usefulness of this biomarker for diagnosis. Additionally it will explore the potential of preoperative neutrophil-lymphocyte ratio (NLR) as a haematological marker to aid in the differentiation of LMS from atypical LM.
Methods
Histologically proven LMS and LM patients between 2013 and 2023 were included. For all patients (191 LM, 18 LMS), the preoperative full blood count was analysed, and the NLR calculated. Whole volume of interest (VOI) and focal region of interest (ROI) areas were manually segmented on patients with DW-MRI sequences available (52 LM, 12 LMS). Mann–Whitney and Fishers exact test were used to assess statistical significance and receiver operating characteristic (ROC) curves for diagnostic performance.
Results
VOI and ROI mean ADC values were significantly lower for LMS than LM, with ROI mean ADC demonstrating greater diagnostic accuracy (area under the curve, [AUC] 0.817 vs 0.755). Applying a threshold ROI mean ADC value of ≤1.00 × 10−3 mm2/s achieved a sensitivity and specificity of 88.3% and 65.4%, respectively. A higher NLR was suggestive of LMS (median 2.8 vs 1.7 for LM).
Conclusions
ADC, particularly a focal ROI is useful in differentiating LMS from LM. Differences in preoperative blood markers, suggest an inflammatory-malignancy relationship. Future risk stratification models of ADC and haematological parameters should be explored. Advances in knowledge This study adds to few studies comparing using both ROI- and VOI-based methods, and no study has assessed both haematological markers and ADC metrics to aid differentiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, London W12 0NN, United Kingdom.
- The Imaging Department, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London W12 0HS, United Kingdom.
- Department of Histopathology, Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital, Imperial College London, London W6 8RF, United Kingdom.
ORCID-Profile: Kavita Shapriya, Nishat Bharwani, Andrea G Rockall
Zitieren
APA
Das, S., Shapriya, K., Da Silva, A., Li, X., Jackson, A., Bharwani, N., Kaur, B., & Rockall, A. G. (2025). Using diffusion-weighted imaging and blood inflammatory markers to preoperatively differentiate between leiomyosarcoma and atypical leiomyomas. British Journal of Radiology. https://doi.org/10.1093/bjr/tqaf172
Vancouver
Das S, Shapriya K, Da Silva A, Li X, Jackson A, Bharwani N, et al. Using diffusion-weighted imaging and blood inflammatory markers to preoperatively differentiate between leiomyosarcoma and atypical leiomyomas. British Journal of Radiology. 2025. doi:10.1093/bjr/tqaf172
BibTeX
@article{Das2025,
author = {Das, Saranya and Shapriya, Kavita and Da Silva, Andrea and Li, Xingfeng and Jackson, Alastair and Bharwani, Nishat and Kaur, Baljeet and Rockall, Andrea G},
title = {Using diffusion-weighted imaging and blood inflammatory markers to preoperatively differentiate between leiomyosarcoma and atypical leiomyomas},
journal = {British Journal of Radiology},
year = {2025},
doi = {10.1093/bjr/tqaf172}
}
EUVIMED